Marotte H, Charrin J E, Miossec P
Lancet. 2001 Nov 24;358(9295):1784. doi: 10.1016/S0140-6736(01)06810-6.
We report an episode of aseptic meningitis in a 53-year-old man, who was treated with infliximab for active rheumatoid arthritis. He had acute, severe muscle pain after initial infusion of the drug, and similar symptoms with a transient lymphocytic meningitis after a subsequent infusion. We measured no change in antibodies to nuclei, DNA, or to neurones. Functional antibodies to infliximab were not induced and concentrations of tumour necrosis factor a in spinal fluid were not raised. This adverse reaction to infliximab might have been caused by inability of the drug to enter the central nervous system.
我们报告了一例53岁男性的无菌性脑膜炎病例,该患者因活动性类风湿关节炎接受英夫利昔单抗治疗。首次输注该药物后,他出现急性、严重的肌肉疼痛,再次输注后出现类似症状并伴有短暂性淋巴细胞性脑膜炎。我们检测到其抗核抗体、抗DNA抗体及抗神经元抗体均无变化。未诱导出针对英夫利昔单抗的功能性抗体,脑脊液中肿瘤坏死因子α的浓度也未升高。英夫利昔单抗的这种不良反应可能是由于药物无法进入中枢神经系统所致。